BTX Quote, Trading Chart, BioTime Inc.
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2019-09-13 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-12 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-11 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-10 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-09 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-06 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-05 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-04 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-03 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-09-02 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-08-30 | N/A | 0.9199 | N/A | N/A | 0 |
| 2019-08-09 | 0.91 | 0.9199 | 0.97 | 0.90 | 695,479 |
| 2019-08-08 | 1.01 | 0.99 | 1.07 | 0.99 | 433,353 |
| 2019-08-07 | 0.99 | 1.01 | 1.0543 | 0.981 | 333,720 |
| 2019-08-06 | 0.99 | 1.01 | 1.06 | 0.9871 | 387,552 |
| 2019-08-05 | 1.03 | 0.9791 | 1.0599 | 0.9791 | 530,340 |
| 2019-08-02 | 1.04 | 1.04 | 1.09 | 1.03 | 360,370 |
| 2019-08-01 | 1.10 | 1.05 | 1.14 | 1.03 | 743,167 |
| 2019-07-31 | 1.18 | 1.10 | 1.19 | 1.10 | 586,071 |
| 2019-07-30 | 1.19 | 1.19 | 1.23 | 1.17 | 393,108 |
News, Short Squeeze, Breakout and More Instantly...
-
Announced Rebranding and Name Change to Lineage Cell Therapeutics and Corporate Relocation Awarded $2.5 Million Grant from the Israel Innovation Authority for Continued Development of OpRegen ® Conducted Sale of 2.25 Million Shares of OncoCyte Corporation Initiated...
-
BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that it will report its second quarter 2019 financial and operating results on Thursday, August 8 th , 2019, following the close of th...
-
New Identity Reflects Commitment to Becoming a Leading Cell Therapy Company Company to Trade on NYSE American Under Ticker “LCTX” at Market Open on August 12, 2019 BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel ce...